Highlights of semi-synthetic developments from erythromycin A
1Pfizer Central Research, Eastern Point Road, Groton, Connecticut 06340, USA. Yong-Jin.Wu@bms.com
Abstract:
Earlier semi-synthetic studies of erythromycin A culminated in the discovery of two successful second generation macrolide antibiotics, azithromycin and clarithromycin, for the treatment of community-acquired bacterial infections. More recent structural modifications of erythromycin A have resulted in the discovery of novel ketolide antibiotics and new motilide prokinetic agents. This review is an account of the semi-synthetic developments from erythromycin A by chemical transformations.
More Related Videos
05:46Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation
Published on: August 1, 2018
07:59A High-Yield Streptomyces Transcription-Translation Toolkit for Synthetic Biology and Natural Product Applications
Published on: September 10, 2021
Related Concept Videos
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Bioreactor Controls-III
Production of Antibiotics
Production of Pharmaceuticals
Inhibitors of Bacterial Protein Synthesis
